19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Depression: Depression & Related Conditions
Resources
Basic Information
Introduction and Types of Depressive DisordersRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Brexit Had Brits Turning to Antidepressants: StudyDepression Is a Risk for Teens, Adults With EpilepsyStimulating One Brain Area May Ease Tough-to-Treat DepressionAnti-Seizure Drug May Be New Weapon Against DepressionMichael Phelps Champions the Fight Against DepressionFacebook Posts May Hint at DepressionDo Dimmer Days in Pregnancy Raise Postpartum Depression Risk?Depression Strikes Nearly 1 in 5 Young Adults With Autism: StudyNew Dads Can Get the Baby Blues, TooHealth Tip: Help a New Mom With Postpartum DepressionCould a Blood Test Help Spot Severe Depression?Treating Depression May Prevent Repeat Heart AttackSupportive Managers Key When a Worker Is DepressedIs Depression During Pregnancy on the Rise?Know the Signs of Postpartum DepressionAre Your Meds Making You Depressed?Depression, Money Woes Higher in Heart Patients With Job LossSnubbed on Social Media? Your Depression Risk May RiseNever Ignore DepressionStudy Affirms What Many Know: Antidepressants May Lead to Weight GainECT Effective for Treatment-Resistant DepressionRates of Major Depression Up Among U.S. Insured, Esp. YouthResistance Exercise May Reduce Depressive Symptoms in AdultsDepression Striking More Young People Than EverDepression May Dampen MemoryCould Mom-to-Be's Antidepressants Have an Upside for Baby's Brain?Exercise Your Blues AwayGrip Strength Indicative of Cognition in Major DepressionKetamine Nasal Spray Shows Promise Against Depression, SuicideTelltale Clues That Your Child Is DepressedPrenatal Exposure to SSRI Tied to Fetal Brain DevelopmentDepressive Symptoms Tied to Diabetes Self-ManagementAbandoning Your Workouts May Bring on the BluesMany Grad Students Struggle With Anxiety, DepressionRelapse in Major Depression Linked to Brain Cortical ChangesIL-6 Levels Predict Response to ECT in Depressive Disorder1 in 20 Younger Women Suffers Major DepressionHeart-Healthy 'DASH' Diet May Also Help Lower Depression RiskGuidelines Updated for Managing and ID'ing Adolescent Depression21 Reviewed Antidepressants Top Placebo for Major DepressionAntidepressants Do Work, Some Better Than Others: StudyTreatment Initiation for Depression Low in Primary CareDuring 2013 to 2016, 8.1 Percent of U.S. Adults Had DepressionDepression Common in U.S., Women Hit HardestNo Proof At-Home 'Cranial Stimulation' Eases DepressionAcne Linked to Increased Risk of Major Depressive DisorderMany With Depression Delay, Avoid TreatmentPostnatal Depression Tied to Child Behavioral ProblemsTalk Therapy May Be Worth It for Teen DepressionCognitive Behavioral Therapy Cost-Effective in Depressed Teens
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management

ECT Effective for Treatment-Resistant Depression


HealthDay News
Updated: May 14th 2018

new article illustration

MONDAY, May 14, 2018 (HealthDay News) -- Electroconvulsive therapy (ECT) may be effective and cost-effective for U.S. patients with treatment-resistant depression, according to research published online May 10 in JAMA Psychiatry.

Eric L. Ross, from the University of Michigan Medical School in Ann Arbor, and colleagues examined the cost-effectiveness of ECT versus pharmacotherapy/psychotherapy for treatment-resistant major depression. Data were included from multiple meta-analyses, randomized trials, and observational studies.

The researchers simulated a population with a mean age of 40.7 years based on the Sequenced Treatment Alternatives to Relieve Depression trial. ECT was projected to reduce time with uncontrolled depression from 50 to 33 to 37 percent of life-years over four years; greater improvements were seen when ECT was offered earlier. There was an increase in mean health care costs by $7,300 to $12,000; the incremental costs were greater when ECT was offered earlier. Third-line ECT was cost-effective in the base case, with an incremental cost-effectiveness ratio of $54,000 per quality-adjusted life-year. In a range of univariate, scenario, and probabilistic sensitivity analyses, third-line ECT remained cost effective. The likelihood that at least one ECT strategy is cost-effective was estimated at 74 to 78 percent incorporating all input data uncertainty; there was a 56 to 58 percent likelihood that third-line ECT was the optimal strategy.

"These data suggest that, from a health-economic standpoint, ECT should be considered after failure of two or more lines of pharmacotherapy/psychotherapy," the authors write.

Abstract/Full Text